These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35469501)

  • 1. Patient's perspective of treatment in Dupuytren's Disease: collagenase versus limited fasciectomy.
    Beecher SM; Wilkinson JE; Cuggy C; O'Shaughnessy M
    J Hand Surg Eur Vol; 2022 Dec; 47(11):1172-1174. PubMed ID: 35469501
    [No Abstract]   [Full Text] [Related]  

  • 2. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.
    Sanjuan-Cervero R; Carrera-Hueso FJ; Vaquero-Perez M; Montaner-Alonso D
    J Hand Surg Eur Vol; 2020 Jun; 45(5):508-512. PubMed ID: 31980000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupuytren's interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial.
    Dias J; Arundel C; Tharmanathan P; Keding A; Welch C; Corbacho B; Armaou M; Leighton P; Bainbridge C; Craigen M; Flett L; Gascoyne S; Hewitt C; James E; James S; Johnson N; Jones J; Knowlson C; Radia P; Torgerson D; Warwick D; Watson M
    Trials; 2021 Sep; 22(1):671. PubMed ID: 34593024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren's Contracture.
    Tay TK; Tien H; Lim EY
    Hand Surg; 2015 Oct; 20(3):386-90. PubMed ID: 26387998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical findings in the treatment of Dupuytren's disease after initial treatment with clostridial collagenase (Xiaflex).
    Hay DC; Louie DL; Earp BE; Kaplan FT; Akelman E; Blazar PE
    J Hand Surg Eur Vol; 2014 Jun; 39(5):463-5. PubMed ID: 23649016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences for Limited Fasciectomy Versus Collagenase Treatment for Dupuytren Contracture.
    Zhang D; Blazar P; Benavent KA; Earp BE
    J Hand Surg Asian Pac Vol; 2022 Apr; 27(2):242-247. PubMed ID: 35404200
    [No Abstract]   [Full Text] [Related]  

  • 8. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
    Zhou C; Hovius SER; Slijper HP; Feitz R; Van Nieuwenhoven CA; Pieters AJ; Selles RW
    Plast Reconstr Surg; 2015 Jul; 136(1):87-97. PubMed ID: 25829153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: A meta-analysis.
    Cooper TB; Poonit K; Yao C; Jin Z; Zheng J; Yan H
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020921747. PubMed ID: 32484064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative Cost Effectiveness of Clostridium Histolyticum Collagenase (Xiapex®) and Partial Fasciectomy for the Treatment of Dupuytren's Contracture in Austria].
    Neuwirth M; Binter A; Pipam W; Rab M
    Handchir Mikrochir Plast Chir; 2016 Aug; 48(4):233-8. PubMed ID: 27547932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease: A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy.
    Eckerdal D; Lauritzson A; Nordenskjöld J; Åkesson A; Atroshi I
    J Hand Surg Am; 2022 Sep; 47(9):834-842. PubMed ID: 35868901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture.
    Peimer CA; Wilbrand S; Gerber RA; Chapman D; Szczypa PP
    J Hand Surg Eur Vol; 2015 Feb; 40(2):141-9. PubMed ID: 24698851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
    Baltzer H; Binhammer PA
    Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discussion: Three-Year Recurrence of Dupuytren Contracture after Needle Fasciotomy or Collagenase Injection: A Randomized Controlled Trial.
    McCullough M; Kulber DA
    Plast Reconstr Surg; 2023 Feb; 151(2):372-373. PubMed ID: 36696320
    [No Abstract]   [Full Text] [Related]  

  • 15. A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand.
    Mehta S; Belcher HJ
    J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):368-72. PubMed ID: 24486152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment options for Dupuytren's surgery: collagenase and percutaneous aponeurotomy.
    Srinivasan RC; Shah AS; Jebson PJ
    J Hand Surg Am; 2010 Aug; 35(8):1362-4. PubMed ID: 20434276
    [No Abstract]   [Full Text] [Related]  

  • 17. A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.
    Harrison E; Tan W; Mills N; Karantana A; Sprange K; Duley L; Elliott D; Blazeby J; Hollingworth W; Montgomery AA; Davis T
    Trials; 2017 Aug; 18(1):392. PubMed ID: 28841903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and adverse effects of collagenase use in the treatment of Dupuytren's disease: a meta-analysis.
    Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Ramon-Barrios MA
    Bone Joint J; 2018 Jan; 100-B(1):73-80. PubMed ID: 29305454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
    Sefton AK; Smith BJ; Stewart DA
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
    Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
    Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.